Interestingly, upregulation of LYPD3 has been observed following cellular stress [60], however, this is the first study showing that treatment of breast cancer cells with the endogenous stress hormone norepinephrine, can also lead to elevated LYPD3 levels. The gene discussed is LYPD3; the disease is breast cancer.